Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Supreme Court: Can drug companies pay to delay generics?
Yahoo/AP
Monday, March 25, 2013 - 10:57am
tags:
pay-for-delay, generics, Supreme Court
2 Can't-Miss FDA Rulings Next Week
Motley Fool
Sunday, March 24, 2013 - 12:27pm
tags:
JNJ, Invokana, type 2 diabetes, diabetes, pulmonary arterial hypertension, Treprostinil
Is Eli Lilly's Management Charting the Right Course?
Motley Fool
Sunday, March 24, 2013 - 12:24pm
tags:
Eli Lilly
Has Horizon Pharma's Share Price Bottomed Out?
Seeking Alpha
Sunday, March 24, 2013 - 12:23pm
tags:
Horizon Phamra
China Biotech In Review: Roche Steps Up As A Bidder For Life Technologies
Seeking Alpha
Sunday, March 24, 2013 - 12:22pm
tags:
BGI, Life Technologies, Roche Holding AG, Simcere, OriGene Technologies, H3 Biomedicine, Eli Lilly, Taiwan Liposome Company, Amoy Diagnostics, Antisense Therapeutics
Is Obamacare a Disaster Waiting to Happen for Big Pharma?
Motley Fool
Sunday, March 24, 2013 - 12:19pm
tags:
Obamacare
Can Johnson & Johnson Turn Around This Lagging Business?
Motley Fool
Sunday, March 24, 2013 - 12:18pm
tags:
JNJ
3SBio Inc. Announces Extraordinary General Meeting of Shareholders
Yahoo/PR Newswire
Sunday, March 24, 2013 - 12:15pm
tags:
3SBio, M&A
3 Humongous Health-Care Stocks This Week
Motley Fool
Sunday, March 24, 2013 - 12:11pm
tags:
Anacor, Obagi Medical Products, Acadia
Takeda seeks Japanese approval for brentuximab vedotin to treat relapsed/refractory CD30 positive HL and ALCL
Pharmabiz
Saturday, March 23, 2013 - 10:15am
tags:
Takeda, brentuximab vedotin, systemic anaplastic large cell lymphoma
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Saturday, March 23, 2013 - 10:06am
tags:
Repros Therapeutics, JNJ, Bristol-Myers Squibb, Watson Pharmaceuticals
Orphan Drug Is Headed Back to Its Parent: NPS Pharmaceuticals, Inc.
Insider Monkey
Saturday, March 23, 2013 - 10:05am
tags:
NPS Pharmaceuticals, revestive, preotact
Valeant Pharmaceuticals Receives “Buy” Rating from Jefferies Group (VRX)
Zolmax
Saturday, March 23, 2013 - 10:01am
tags:
Valeant Pharmaceuticals
3 Pharmaceutical Stocks to Sell Now
InvestorPlace
Saturday, March 23, 2013 - 9:59am
tags:
Corcept Therapeutics, Vivus, Cempra
Why Anacor Cannot Be Contained (video)
Motley Fool
Saturday, March 23, 2013 - 9:53am
tags:
Anacor
Gilead Keeps on Building (video)
Motley Fool
Saturday, March 23, 2013 - 9:53am
tags:
Gilead Sciences
Rockwell Poised For Post-Offering Bounce Ahead Of Phase III Results
Seeking Alpha
Saturday, March 23, 2013 - 9:52am
tags:
Rockwell Medical, Soluble Ferric Pyrophosphate, renal disease
Will This Treatment Help Anacor’s Stock Soar?
Wall Street Cheat Street
Saturday, March 23, 2013 - 9:50am
tags:
Anacor, AN2728, eczema
Reasons To Consider Eli Lilly Over Other Pharmaceutical Giants
Seeking Alpha
Saturday, March 23, 2013 - 9:49am
tags:
Eli Lilly
U.K. Regulators Sour on Novartis Breast Cancer Drug Afinitor
Motley Fool
Saturday, March 23, 2013 - 9:48am
tags:
Novartis, Afinitor, breast cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.